greeksoup/ stock research
Stock research / United States / NVCR / Documents

NovoCure Ltd. documents

NovoCure (NVCR) annual report: the 10-K filed 26 February 2026 for the year ended 31 December 2025. Proxy statement (DEF 14A) filed 20 April 2026; latest 10-Q filed 23 July 2026 for the quarter ended 30 June 2026. Each links to the document on EDGAR, with 5 earnings press releases.

Earnings press releases (exhibit 99 to each results 8-K)

FiledDocumentOpenWhere
23 July 2026Results press release, exhibit 99 to the 8-K filed 23 July 2026The releaseEDGAR folder
30 April 2026Results press release, exhibit 99 to the 8-K filed 30 April 2026The releaseEDGAR folder
26 February 2026Results press release, exhibit 99 to the 8-K filed 26 February 2026The releaseEDGAR folder
12 January 2026Results press release, exhibit 99 to the 8-K filed 12 January 2026The releaseEDGAR folder
30 October 2025Results press release, exhibit 99 to the 8-K filed 30 October 2025The releaseEDGAR folder

Annual reports (10-K)

FiledDocumentOpenWhere
26 February 202610-K, period ended 31 December 2025The documentEDGAR folder

Quarterly reports (10-Q)

FiledDocumentOpenWhere
23 July 202610-Q, period ended 30 June 2026The documentEDGAR folder
30 April 202610-Q, period ended 31 March 2026The documentEDGAR folder
30 October 202510-Q, period ended 30 September 2025The documentEDGAR folder

Proxy statements

FiledDocumentOpenWhere
20 April 2026DEF 14A, period ended 3 June 2026The documentEDGAR folder